The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Truist Securities on December 18, 2025. The analyst firm set a price target for $47.00 expecting PRCT to rise to within 12 ...
PROCEPT BioRobotics (NASDAQ:PRCT) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of ...
SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
Throughout the last three months, 7 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...
Procept BioRobotics Corporation is in the early stages of penetrating a massive $20B BPH surgery market with its innovative, recurring-revenue robotic systems. The company’s strong revenue and install ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) just released its third-quarter report and things are looking bullish. It looks like a positive result overall, with revenues of US$83m beating forecasts ...
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Total revenue for the first quarter of 2025 was $69.2 million, an increase of 55% compared to the prior year period. U.S. revenue was $60.3 million, representing growth of 50% compared to the prior ...
Procept Biorobotics Corp’s stock reached a 52-week low, touching 33.96 USD. According to InvestingPro data, the company maintains strong financial health with a current ratio of 9.21, indicating ...
Procept Biorobotics Corp’s stock recently reached a 52-week low, hitting a price of 29.78 USD. This milestone reflects a significant downturn for the company, which has experienced a substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback